Overview:

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
* Includes a five-year forecast of the industry

Highlights

The global pharmaceuticals market grew by 4.3% in 2010 to reach a value of $693 billion.

In 2015, the global pharmaceuticals market is forecast to have a value of $917.1 billion, an increase of 32.3% since 2010.

Other therapeutic purposes is the largest segment of the global pharmaceuticals market, accounting for 32% of the market's total value.

Americas accounts for 51.8% of the global pharmaceuticals market value.

Pfizer Inc. is the leading player in the global pharmaceuticals market, generating a 10% share of the market's value.

Why you should buy this report

* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2009 annual average exchange rates.

ABOUT DATAMONITOR 2
EXECUTIVE SUMMARY 3
INTRODUCTION 26
What is this report about? 26
Who is the target reader? 26
How to use this report 26
Definitions 26
GLOBAL PHARMACEUTICALS 27
Market Overview 27
Market Value 28
Market Segmentation I 29
Market Segmentation Ii 30
Market Share 31
Five Forces Analysis 32
Market Forecasts 42
PHARMACEUTICALS IN ASIA-PACIFIC 44
Market Overview 44
Market Value 45
Market Segmentation I 46
Market Segmentation Ii 47
Market Share 48
Five Forces Analysis 49
Market Forecasts 58
PHARMACEUTICALS IN EUROPE 60
Market Overview 60
Market Value 61
Market Segmentation I 62
Market Segmentation Ii 63
Market Share 64
Five Forces Analysis 65
Market Forecasts 74
PHARMACEUTICALS IN FRANCE 75
Market Overview 75
Market Value 76
Market Segmentation I 77
Market Segmentation Ii 78
Market Share 79
Five Forces Analysis 80
Market Forecasts 89
Macroeconomic Indicators 90
PHARMACEUTICALS IN GERMANY 92
Market Overview 92
Market Value 93
Market Segmentation I 94
Market Segmentation Ii 95
Market Share 96
Five Forces Analysis 97
Market Forecasts 106
Macroeconomic Indicators 107
PHARMACEUTICALS IN ITALY 109
Market Overview 109
Market Value 110
Market Segmentation I 111
Market Segmentation Ii 112
Market Share 113
Five Forces Analysis 114
Market Forecasts 123
Macroeconomic Indicators 124
PHARMACEUTICALS IN JAPAN 126
Market Overview 126
Market Value 127
Market Segmentation I 128
Market Segmentation Ii 129
Market Share 130
Five Forces Analysis 131
Market Forecasts 140
Macroeconomic Indicators 141
PHARMACEUTICALS IN BELGIUM 143
Market Overview 143
Market Value 144
Market Segmentation I 145
Market Segmentation Ii 146
Market Share 147
Five Forces Analysis 148
Market Forecasts 156
Macroeconomic Indicators 157
PHARMACEUTICALS IN CANADA 159
Market Overview 159
Market Value 160
Market Segmentation I 161
Market Segmentation Ii 162
Market Share 163
Five Forces Analysis 164
Market Forecasts 172
Macroeconomic Indicators 173
PHARMACEUTICALS IN CHINA 175
Market Overview 175
Market Value 176
Market Segmentation I 177
Market Segmentation Ii 178
Market Share 179
Five Forces Analysis 180
Market Forecasts 189
Macroeconomic Indicators 190
PHARMACEUTICALS IN THE NETHERLANDS 192
Market Overview 192
Market Value 193
Market Segmentation I 194
Market Segmentation Ii 195
Market Share 196
Five Forces Analysis 197
Market Forecasts 206
Macroeconomic Indicators 208
PHARMACEUTICALS IN SPAIN 210
Market Overview 210
Market Value 211
Market Segmentation I 212
Market Segmentation Ii 213
Market Share 214
Five Forces Analysis 215
Market Forecasts 224
Macroeconomic Indicators 225
PHARMACEUTICALS IN THE UNITED KINGDOM 227
Market Overview 227
Market Value 228
Market Segmentation I 229
Market Segmentation Ii 230
Market Share 231
Five Forces Analysis 232
Market Forecasts 243
Macroeconomic Indicators 245
PHARMACEUTICALS IN THE UNITED STATES 247
Market Overview 247
Market Value 248
Market Segmentation I 249
Market Segmentation Ii 250
Market Share 251
Five Forces Analysis 252
Market Forecasts 262
Macroeconomic Indicators 264
COMPANY PROFILES 266
Merck & Co., Inc. 266
Novartis AG 271
Pfizer Inc. 276
Sanofi-Aventis SA 281
APPENDIX 286
Data Research Methodology 286

LIST OF TABLES
Table 1: Global pharmaceuticals market value: $ billion, 2006–10(e) 28
Table 2: Global pharmaceuticals market segmentation I:% share, by value, 2010(e) 29
Table 3: Global pharmaceuticals market segmentation II: % share, by value, 2010(e) 30
Table 4: Global pharmaceuticals market share: % share, by value, 2010(e) 31
Table 5: Global pharmaceuticals market value forecast: $ billion, 2010–15 42
Table 6: Asia-Pacific pharmaceuticals market value: $ billion, 2006–10(e) 45
Table 7: Asia-Pacific pharmaceuticals market segmentation I:% share, by value, 2010(e) 46
Table 8: Asia-Pacific pharmaceuticals market segmentation II: % share, by value, 2010(e) 47
Table 9: Asia-Pacific pharmaceuticals market share: % share, by value, 2010(e) 48
Table 10: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2010–15 58
Table 11: Europe pharmaceuticals market value: $ billion, 2006–10(e) 61
Table 12: Europe pharmaceuticals market segmentation I:% share, by value, 2010(e) 62
Table 13: Europe pharmaceuticals market segmentation II: % share, by value, 2010(e) 63
Table 14: Europe pharmaceuticals market share: % share, by value, 2010(e) 64
Table 15: Europe pharmaceuticals market value forecast: $ billion, 2010–15 74
Table 16: France pharmaceuticals market value: $ billion, 2006–10(e) 76
Table 17: France pharmaceuticals market segmentation I:% share, by value, 2010(e) 77
Table 18: France pharmaceuticals market segmentation II: % share, by value, 2010(e) 78
Table 19: France pharmaceuticals market share: % share, by value, 2010(e) 79
Table 20: France pharmaceuticals market value forecast: $ billion, 2010–15 89
Table 21: France size of population (million), 2006–10 90
Table 22: France GDP (constant 2000 prices, $ billion), 2006–10 90
Table 23: France GDP (current prices, $ billion), 2006–10 90
Table 24: France inflation, 2006–10 91
Table 25: France consumer price index (absolute), 2006–10 91
Table 26: France exchange rate, 2006–10 91
Table 27: Germany pharmaceuticals market value: $ billion, 2006–10(e) 93
Table 28: Germany pharmaceuticals market segmentation I:% share, by value, 2010(e) 94
Table 29: Germany pharmaceuticals market segmentation II: % share, by value, 2010(e) 95
Table 30: Germany pharmaceuticals market share: % share, by value, 2010(e) 96
Table 31: Germany pharmaceuticals market value forecast: $ billion, 2010–15 106
Table 32: Germany size of population (million), 2006–10 107
Table 33: Germany GDP (constant 2000 prices, $ billion), 2006–10 107
Table 34: Germany GDP (current prices, $ billion), 2006–10 107
Table 35: Germany inflation, 2006–10 108
Table 36: Germany consumer price index (absolute), 2006–10 108
Table 37: Germany exchange rate, 2006–10 108
Table 38: Italy pharmaceuticals market value: $ billion, 2006–10(e) 110
Table 39: Italy pharmaceuticals market segmentation I:% share, by value, 2010(e) 111
Table 40: Italy pharmaceuticals market segmentation II: % share, by value, 2010(e) 112
Table 41: Italy pharmaceuticals market share: % share, by value, 2010(e) 113
Table 42: Italy pharmaceuticals market value forecast: $ billion, 2010–15 123
Table 43: Italy size of population (million), 2006–10 124
Table 44: Italy GDP (constant 2000 prices, $ billion), 2006–10 124
Table 45: Italy GDP (current prices, $ billion), 2006–10 124
Table 46: Italy inflation, 2006–10 125
Table 47: Italy consumer price index (absolute), 2006–10 125
Table 48: Italy exchange rate, 2006–10 125
Table 49: Japan pharmaceuticals market value: $ billion, 2006–10(e) 127
Table 50: Japan pharmaceuticals market segmentation I:% share, by value, 2010(e) 128
Table 51: Japan pharmaceuticals market segmentation II: % share, by value, 2010(e) 129
Table 52: Japan pharmaceuticals market share: % share, by value, 2010(e) 130
Table 53: Japan pharmaceuticals market value forecast: $ billion, 2010–15 140
Table 54: Japan size of population (million), 2006–10 141
Table 55: Japan GDP (constant 2000 prices, $ billion), 2006–10 141
Table 56: Japan GDP (current prices, $ billion), 2006–10 141
Table 57: Japan inflation, 2006–10 142
Table 58: Japan consumer price index (absolute), 2006–10 142
Table 59: Japan exchange rate, 2006–10 142
Table 60: Belgium pharmaceuticals market value: $ billion, 2006–10(e) 144
Table 61: Belgium pharmaceuticals market segmentation I:% share, by value, 2010(e) 145
Table 62: Belgium pharmaceuticals market segmentation II: % share, by value, 2010(e) 146
Table 63: Belgium pharmaceuticals market share: % share, by value, 2010(e) 147
Table 64: Belgium pharmaceuticals market value forecast: $ billion, 2010–15 156
Table 65: Belgium size of population (million), 2006–10 157
Table 66: Belgium GDP (constant 2000 prices, $ billion), 2006–10 157
Table 67: Belgium GDP (current prices, $ billion), 2006–10 157
Table 68: Belgium inflation, 2006–10 158
Table 69: Belgium consumer price index (absolute), 2006–10 158
Table 70: Belgium exchange rate, 2006–10 158
Table 71: Canada pharmaceuticals market value: $ billion, 2006–10(e) 160
Table 72: Canada pharmaceuticals market segmentation I:% share, by value, 2010(e) 161
Table 73: Canada pharmaceuticals market segmentation II: % share, by value, 2010(e) 162
Table 74: Canada pharmaceuticals market share: % share, by value, 2010(e) 163
Table 75: Canada pharmaceuticals market value forecast: $ billion, 2010–15 172
Table 76: Canada size of population (million), 2006–10 173
Table 77: Canada GDP (constant 2000 prices, $ billion), 2006–10 173
Table 78: Canada GDP (current prices, $ billion), 2006–10 173
Table 79: Canada inflation, 2006–10 174
Table 80: Canada consumer price index (absolute), 2006–10 174
Table 81: Canada exchange rate, 2006–10 174
Table 82: China pharmaceuticals market value: $ billion, 2006–10(e) 176
Table 83: China pharmaceuticals market segmentation I:% share, by value, 2010(e) 177
Table 84: China pharmaceuticals market segmentation II: % share, by value, 2010(e) 178
Table 85: China pharmaceuticals market share: % share, by value, 2010(e) 179
Table 86: China pharmaceuticals market value forecast: $ billion, 2010–15 189
Table 87: China size of population (million), 2006–10 190
Table 88: China GDP (constant 2000 prices, $ billion), 2006–10 190
Table 89: China GDP (current prices, $ billion), 2006–10 190
Table 90: China inflation, 2006–10 191
Table 91: China consumer price index (absolute), 2006–10 191
Table 92: China exchange rate, 2006–10 191
Table 93: Netherlands pharmaceuticals market value: $ billion, 2006–10(e) 193
Table 94: Netherlands pharmaceuticals market segmentation I:% share, by value, 2010(e) 194
Table 95: Netherlands pharmaceuticals market segmentation II: % share, by value, 2010(e) 195
Table 96: Netherlands pharmaceuticals market share: % share, by value, 2010(e) 196
Table 97: Netherlands pharmaceuticals market value forecast: $ billion, 2010–15 206
Table 98: Netherlands size of population (million), 2006–10 208
Table 99: Netherlands GDP (constant 2000 prices, $ billion), 2006–10 208
Table 100: Netherlands GDP (current prices, $ billion), 2006–10 208
Table 101: Netherlands inflation, 2006–10 209
Table 102: Netherlands consumer price index (absolute), 2006–10 209
Table 103: Netherlands exchange rate, 2006–10 209
Table 104: Spain pharmaceuticals market value: $ billion, 2006–10(e) 211
Table 105: Spain pharmaceuticals market segmentation I:% share, by value, 2010(e) 212
Table 106: Spain pharmaceuticals market segmentation II: % share, by value, 2010(e) 213
Table 107: Spain pharmaceuticals market share: % share, by value, 2010(e) 214
Table 108: Spain pharmaceuticals market value forecast: $ billion, 2010–15 224
Table 109: Spain size of population (million), 2006–10 225
Table 110: Spain GDP (constant 2000 prices, $ billion), 2006–10 225
Table 111: Spain GDP (current prices, $ billion), 2006–10 225
Table 112: Spain inflation, 2006–10 226
Table 113: Spain consumer price index (absolute), 2006–10 226
Table 114: Spain exchange rate, 2006–10 226
Table 115: United Kingdom pharmaceuticals market value: $ billion, 2006–10(e) 228
Table 116: United Kingdom pharmaceuticals market segmentation I:% share, by value, 2010(e) 229
Table 117: United Kingdom pharmaceuticals market segmentation II: % share, by value, 2010(e) 230
Table 118: United Kingdom pharmaceuticals market share: % share, by value, 2010(e) 231
Table 119: United Kingdom pharmaceuticals market value forecast: $ billion, 2010–15 243
Table 120: United Kingdom size of population (million), 2006–10 245
Table 121: United Kingdom GDP (constant 2000 prices, $ billion), 2006–10 245
Table 122: United Kingdom GDP (current prices, $ billion), 2006–10 245
Table 123: United Kingdom inflation, 2006–10 246
Table 124: United Kingdom consumer price index (absolute), 2006–10 246
Table 125: United Kingdom exchange rate, 2006–10 246
Table 126: United States pharmaceuticals market value: $ billion, 2006–10(e) 248
Table 127: United States pharmaceuticals market segmentation I:% share, by value, 2010(e) 249
Table 128: United States pharmaceuticals market segmentation II: % share, by value, 2010(e) 250
Table 129: United States pharmaceuticals market share: % share, by value, 2010(e) 251
Table 130: United States pharmaceuticals market value forecast: $ billion, 2010–15 262
Table 131: United States size of population (million), 2006–10 264
Table 132: United States GDP (constant 2000 prices, $ billion), 2006–10 264
Table 133: United States GDP (current prices, $ billion), 2006–10 264
Table 134: United States inflation, 2006–10 265
Table 135: United States consumer price index (absolute), 2006–10 265
Table 136: United States exchange rate, 2006–10 265
Table 137: Merck & Co., Inc.: key facts 266
Table 138: Merck & Co., Inc.: key financials ($) 268
Table 139: Merck & Co., Inc.: key financial ratios 269
Table 140: Novartis AG: key facts 271
Table 141: Novartis AG: key financials ($) 273
Table 142: Novartis AG: key financial ratios 273
Table 143: Pfizer Inc.: key facts 276
Table 144: Pfizer Inc.: key financials ($) 278
Table 145: Pfizer Inc.: key financial ratios 278
Table 146: Sanofi-Aventis SA: key facts 281
Table 147: Sanofi-Aventis SA: key financials ($) 283
Table 148: Sanofi-Aventis SA: key financials (€) 283
Table 149: Sanofi-Aventis SA: key financial ratios 284